Prime Capital Investment Advisors, LLC Jazz Pharmaceuticals PLC Transaction History
Prime Capital Investment Advisors, LLC
- $6.71 Billion
- Q4 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 2,625 shares of JAZZ stock, worth $355,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,625
Previous 2,619
0.23%
Holding current value
$355,398
Previous $291,000
11.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59.1MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$832 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$817 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$343 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$300 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$276 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.49B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...